In the present study, we report a case of a female infant with a de novo unbalanced t(14;15) translocation resulting in a 14-Mb deletion of the 15q11.1q14 region. The deletion includes the 15q11.2q13 Prader-Willi syndrome (PWS) critical region, while no known deleted genes are found in the 14qter region. According to literature review, patients with similar or larger deletions in the 15q region exhibit an expanded phenotype of PWS with case-specific atypical features such as severe retardation, absence of speech, microcephaly, retrognathia, bifid uvula, ear malformations, and heart defects in addition to typical features of PWS. Our proband exhibited increased deep tendon reflexes, an atypical feature which is not reported in the reviewed literature. The severity of the phenotype is not directly associated with the size of the deletion; however, using a combination of methods, the identification of breakpoints and the deleted genes can be helpful for the prognostication in patients with atypical PWS deletions.

1.
Abeliovich D, Dagan J, Lerer I, Silberstein S, Katznelson MBM, Frydman M: t(15;21)(q15;q22. 1) pat resulting in partial trisomy and partial monosomy of chromosomes 15 and 21 in two offspring. Am J Med Genet 66:45-51 (1996).
2.
Angulo MA, Butler MG, Cataletto ME: Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Invest 38:1249-1263 (2015).
3.
Bittel DC, Butler MG: Prader-Willi syndrome: clinical genetics, cytogenetics and molecular biology. Expert Rev Mol Med 7:1-20 (2005).
4.
Bolzán AD: Chromosomal aberrations involving telomeres and interstitial telomeric sequences. Mutagenesis 27:1-15 (2012).
5.
Bolzán AD, Bianchi MS: Telomeres, interstitial telomeric repeat sequences, and chromosomal aberrations. Mutat Res 612:189-214 (2006).
6.
Bonaglia MC, Kurtas NE, Errichiello E, Bertuzzo S, Beri S, et al: De novo unbalanced translocations have a complex history/aetiology. Hum Genet 137:817-829 (2018).
7.
Buiting K: Prader-Willi syndrome and Angelman syndrome. Am J Med Genet C Semin Med Genet 154C:365-376 (2010).
8.
Butler MG, Palmer CG: Parental origin of chromosome 15 deletion in Prader-Willi syndrome. Lancet 1:1285-1286 (1983).
9.
Butler MG, Bittel DC, Kibiryeva N, Cooley LD, Yu S: An interstitial 15q11-q14 deletion: expanded Prader-Willi syndrome phenotype. Am J Med Genet A 152A:404-408 (2010).
10.
Butler MG, Hartin SN, Hossain WA, Manzardo AM, Kimonis V, et al: Molecular genetic classification in Prader-Willi syndrome: a multisite cohort study. J Med Genet 56:149-153 (2019).
11.
Cassidy SB, Schwartz S, Miller JL, Driscoll DJ: Prader-Willi syndrome. Genet Med 14:10-26 (2012).
12.
Cheon CK: Genetics of Prader-Willi syndrome and Prader-Will-like syndrome. Ann Pediatr Endocrinol Metab 21:126-135 (2016).
13.
Conte F, Oti M, Dixon J, Carels CE, Rubini M, Zhou H: Systematic analysis of copy number variants of a large cohort of orofacial cleft patients identifies candidate genes for orofacial clefts. Hum Genet 135:41-59 (2016).
14.
Cuoco C, Bicocchi MP, Granata D, Mezzano P, Serra G: De novo (15;21) unbalanced translocation of paternal origin in a girl with Prader-Willi syndrome. Am J Med Genet 37:62-64 (1990).
15.
Deans MR, Volgyi B, Goodenough DA, Bloomfield SA, Paul DL: Connexin36 is essential for transmission of rod-mediated visual signals in the mammalian retina. Neuron 36:703-712 (2002).
16.
Duker AL, Ballif BC, Bawle EV, Person RE, Mahadevan S, et al: Paternally inherited microdeletion at 15q11.2 confirms a significant role for the SNORD116 C/D box snoRNA cluster in Prader-Willi syndrome. Eur J Hum Genet 18:1196-1201 (2010).
17.
Elder F, Nichols M, Hood O, Harrison WR 3rd: Unbalanced translocation (15; 17)(q13; p13. 3) with apparent Prader‐Willi syndrome but without Miller‐Dieker syndrome. Am J Med Genet 20:519-524 (1985).
18.
Erdogan F, Ullmann R, Chen W, Schubert M, Adolph S, et al: Characterization of a 5.3 Mb deletion in 15q14 by comparative genomic hybridization using a whole genome “tiling path” BAC array in a girl with heart defect, cleft palate, and developmental delay. Am J Med Genet A 143A:172-178 (2007).
19.
Fong BF, De Vries JIP: Obstetric aspects of the Prader-Willi syndrome. Ultrasound Obst Gyn 21:389-392 (2003).
20.
Fontana P, Grasso M, Acquaviva F, Gennaro E, Galli ML, et al: SNORD116 deletions cause Prader-Willi syndrome with a mild phenotype and macrocephaly. Clin Genet 92:440-443 (2017).
21.
Geysenbergh B, De Catte L, Vogels A: Can fetal ultrasound result in prenatal diagnosis of Prader-Willi syndrome? Genetic Couns 22:207-216 (2011).
22.
Hickey SE, Thrush DL, Walters-Sen L, Reshmi SC, Astbury C, et al: A case of an atypically large proximal 15q deletion as cause for Prader-Willi syndrome arising from a de novo unbalanced translocation. Eur J Med Genet 56:510-514 (2013).
23.
Ho-Ming L: Adult Prader-Willi syndrome: an update on management. Case Rep Genet 2016:5251912-5251912 (2016).
24.
Hoppman-Chaney N, Wain K, Seger P, Superneau D, Hodge J: Identification of single gene deletions at 15q13.3: further evidence that CHRNA7 causes the 15q13.3 microdeletion syndrome phenotype. Clin Genet 83:345-351 (2013).
25.
Horsthemke B, Buiting K: Imprinting defects on human chromosome 15. Cytogenet Genome Res 113:292-299 (2006).
26.
ISCN 2016: An International System for Human Cytogenomic Nomenclature; McGowen-Jordan J, Simons A, Schmid M (eds). Cytogenet Genome Res 149:1-140 (2016).
27.
Johansson S, Berland S, Gradek GA, Bongers E, de Leeuw N, et al: Haploinsufficiency of MEIS2 is associated with orofacial clefting and learning disability. Am J Med Genet A 164A:1622-1626 (2014).
28.
Kim SJ, Miller JL, Kuipers PJ, German JR, Beaudet AL, et al: Unique and atypical deletions in Prader-Willi syndrome reveal distinct phenotypes. Eur J Hum Genet 20:283-290 (2012).
29.
Klein OD, Cotter PD, Albertson DG, Pinkel D, Tidyman WE, et al: Prader-Willi syndrome resulting from an unbalanced translocation: characterization by array comparative genomic hybridization. Clin Genet 65:477-482 (2004).
30.
Kloosterman WP, Guryev V, van Roosmalen M, Duran KJ, de Bruijn E, et al: Chromothripsis as a mechanism driving complex de novo structural rearrangements in the germline. Hum Mol Genet 20:1916-1924 (2011).
31.
Kucerová M, Straková M, Polívková Z: The Prader-Willi syndrome with a 15/3 translocation. J Med Genet 16:234-235 (1979).
32.
Ledbetter DH, Riccardi VM, Airhart SD, Strobel RJ, Keenan BS, Crawford JD: Deletions of chromosome 15 as a cause of the Prader-Willi syndrome. N Engl J Med 304:325-329 (1981).
33.
Liu APY, Tang WF, Lau ET, Chan KYK, Kan ASY, et al: Expanded Prader-Willi syndrome due to chromosome 15q11.2-14 deletion: report and a review of literature. Am J Med Genet A 161A:1309-1318 (2013).
34.
Louw JJ, Corveleyn A, Jia Y, Hens G, Gewillig M, Devriendt K: MEIS2 involvement in cardiac development, cleft palate, and intellectual disability. Am J Med Genet A 167A:1142-1146 (2015).
35.
Matsson H, Eason J, Bookwalter CS, Klar J, Gustavsson P, et al: Alpha-cardiac actin mutations produce atrial septal defects. Hum Mol Genet 17:256-265 (2008).
36.
Matsumura M, Kubota T, Hidaka E, Wakui K, Kadowaki S, et al: “Severe” Prader-Willi syndrome with a large deletion of chromosome 15 due to an unbalanced t(15,22)(q14; q11.2) translocation. Clin Genet 63:79-81 (2003).
37.
Mignon-Ravix C, Depetris D, Luciani JJ, Cuoco C, Krajewska-Walasek M, et al: Recurrent rearrangements in the proximal 15q11-q14 region: a new breakpoint cluster specific to unbalanced translocations. Eur J Hum Genet 15:432-440 (2007).
38.
Ming PM, Goodner DM, Park TS: Chromosome 6/15 translocation with multiple congenital anomalies. Obstet Gynecol 49:251-253 (1977).
39.
Monserrat L, Hermida-Prieto M, Fernandez X, Rodríguez I, Dumont C, et al: Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects. Eur Heart J 28:1953-1961 (2007).
40.
Mori M, Rodriguez L, Pinel I, Casas J, de Bustamante Diaz A, Martinez-Frias M: Partial monosomy 15q due to de novo t(15;22)(q15;p11). Ann Genet 30:246-248 (1987).
41.
Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT: Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 280:750-752 (1998).
42.
Pauli RM, Meisner LF, Szmanda RJ: ‘Expanded' Prader-Willi syndrome in a boy with an unusual 15q chromosome deletion. Am J Dis Child 137:1087-1089 (1983).
43.
Prader A, Labhart A, Willi H: Ein syndrom von adipositas, kleinwuchs, kryptorchismus und oligophrenie nach myatonieartigem zustand im neugeborenenalter. Schweiz Med Wochenschr 86:1260-1261 (1956).
44.
Pujana MA, Nadal M, Guitart M, Armengol L, Gratacòs M, Estivill X: Human chromosome 15q11-q14 regions of rearrangements contain clusters of LCR15 duplicons. Eur J Hum Genet 10:26-35 (2002).
45.
Robberecht C, Voet T, Zamani Esteki M, Nowakowska BA, Vermeesch JR: Nonallelic homologous recombination between retrotransposable elements is a driver of de novo unbalanced translocations. Genome Res 23:411-418 (2013).
46.
Ruiz Campo L, Savirón Cornudella R, Gámez Alderete F, Martínez-Payo C, Pérez Pérez P, et al: Prenatal diagnosis of umbilical cord cyst: clinical significance and prognosis. Taiwan J Obstet Gynecol 56:622-627 (2017).
47.
Sahoo T, del Gaudio D, German JR, Shinawi M, Peters SU, et al: Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat Genet 40:719-721 (2008).
48.
Schwartz S, Max SR, Panny SR, Cohen MM: Deletions of proximal 15q and non-classical Prader-Willi syndrome phenotypes. Am J Med Genet 20:255-263 (1985).
49.
Shinawi M, Schaaf CP, Bhatt SS, Xia Z, Patel A, et al: A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes. Nat Genet 41:1269-1271 (2009).
50.
Smith A, Jauch A, St Heaps L, Robson L, Kearney B: Unbalanced translocation t(15;22) in “severe” Prader-Willi syndrome. Ann Genet 43:125-130 (2000).
51.
Varela MC, Lopes GMP, Koiffmann CP: Prader-Willi syndrome with an unusually large 15q deletion due to an unbalanced translocation t(4;15). Ann Genet 47:267-273 (2004).
52.
Weckselblatt B, Hermetz KE, Rudd MK: Unbalanced translocations arise from diverse mutational mechanisms including chromothripsis. Genome Res 25:937-947 (2015).
53.
Windpassinger C, Petek E, Wagner K, Langmann A, Buiting K, Kroisel PM: Molecular characterization of a unique de novo 15q deletion associated with Prader-Willi syndrome and central visual impairment. Clin Genet 63:297-302 (2003).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.